{
    "Trade/Device Name(s)": [
        "UCP Rapid\u2122 Drug Screening Test Strips",
        "UCP Rapid\u2122 Drug Screening Test Devices"
    ],
    "Submitter Information": "UCP Biosciences, Inc",
    "510(k) Number": "K050540",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "DIS",
        "JXM",
        "LDJ",
        "DIO",
        "DJC",
        "DJG",
        "LCM"
    ],
    "Summary Letter Date": "April 29, 2005",
    "Summary Letter Received Date": "March 2, 2005",
    "Submission Date": "February 28, 2005",
    "Regulation Number(s)": [
        "21CFR862.3100",
        "21CFR862.3150",
        "21CFR862.3170",
        "21CFR862.3250",
        "21CFR862.3610",
        "21CFR862.3620",
        "21CFR862.3870"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Barbiturate test system",
        "Benzodiazepine test system",
        "Cocaine and cocaine metabolite test system",
        "Methamphetamine test system",
        "Opiate test system",
        "Methadone test system",
        "Phencyclidine test system",
        "Cannabinoid test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Barbiturate",
        "Benzodiazepine",
        "Cocaine",
        "Methamphetamine",
        "MDMA",
        "Opiates",
        "Methadone",
        "Oxycodone",
        "Phencyclidine",
        "Cannabinoids",
        "D-Amphetamine",
        "Secobarbital",
        "Oxazepam",
        "Benzoylecgonine",
        "D-Methamphetamine",
        "D,L-MDMA",
        "Morphine",
        "11-nor-\u03949-THC-COOH"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Competitive binding immunoassay",
        "Lateral flow immunochromatographic assay"
    ],
    "Methodologies": [
        "Immunochromatography",
        "Lateral flow assay"
    ],
    "Submission Type(s)": [
        "Test",
        "Device",
        "Strip"
    ],
    "Document Summary": "FDA 510(k) summary for UCP Rapid\u2122 Drug Screening Test Strips and Devices for qualitative detection of drugs of abuse in urine using lateral flow immunochromatographic assay.",
    "Indications for Use Summary": "Qualitative, rapid screening of Amphetamine, Barbiturate, Benzodiazepine, Cocaine, Methamphetamine, MDMA, Opiates, Methadone, Oxycodone, Phencyclidine, Marijuana and their metabolites in human urine at specified cutoff concentrations; provides preliminary results that should be confirmed by other methods such as GC/MS.",
    "fda_folder": "Toxicology"
}